Waters Corporation has unveiled the Waters Xevo MRT P10 Mass Spectrometer at the 74th ASMS Conference on Mass Spectrometry and Allied Topics. The high-resolution Quadrupole Time-of-Flight (QToF) System delivers up to 20x higher MS/MS sensitivity compared to its predecessor along with higher speed and expanded acquisition modes to comprehensively support both targeted and untargeted analysis in a single benchtop platform.
The system is designed to accelerate biomarker discovery and validation while supporting the identification of disease pathways and therapeutic targets across large-cohort biomedical research and epidemiology studies.
When the Xevo MRT P10 MS is combined with the DESI XS ion source, rapid spatial analysis is unlocked down to the cellular level at up to 200 Hz, increasing throughput six-fold while preserving image quality, according to Waters data.
The Xevo MRT P10 MS is perfectly positioned to support long-term growth across multiomics, including proteomics, lipidomics, and metabolomics, as well as biopharmaceutical analysis and drug discovery. The instrument unlocks new workflows in high-throughput, deep proteome discovery by combining greater sensitivity with ultra-fast acquisition rates and advanced acquisition modes, allowing confident detection of low-abundance peptides and comprehensive protein identification with rapid separations at scale.
The Xevo MRT P10 MS is expected to be available globally beginning summer 2026.
Visit Waters for more information
